Interestingly, in PD patients, these redox balance alterations were only observed in PMNs, showing higher CAT and lower SOD activities (Figure 2C,G) than NDD-CKD patients (see p-values in Figure 2). The gene discussed is SOD1; the disease is Neurodevelopmental delay.